Latest Period
Q4 2025
Security Snapshot
MAINZ BIOMED N.V. - Ordinary Shares, nominal value of 0.01 per share (QUCY) Institutional Ownership
CUSIP: N5436L119
13F Institutional Holders and Ownership History from Q4 2024 to Q1 2026
Institutions Reporting
18
Shares (Excl. Options)
1,131,702
Price
$1.12
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.
- Type / Class
- Equity / Ordinary Shares, nominal value of 0.01 per share
- Symbol
- QUCY on Nasdaq
- Shares outstanding
- 8,720,000
- Price per share
- $0.48
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 1,131,702
- Total reported value
- $1,267,155
- % of total 13F portfolios
- 0%
- Share change
- +649,871
- Value change
- +$708,602
- Number of holders
- 18
- Price from insider filings
- $0.48
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- QUCY - MAINZ BIOMED N.V. - Ordinary Shares, nominal value of 0.01 per share is tracked under CUSIP N5436L119.
- 18 institutions reported positions in Q4 2025.
- 1 significant owner is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 18 to 2 between Q4 2025 and Q1 2026.
- Reported value moved from $1,267,155 to $598.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Source Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 18 institutions filings for Q4 2025.
Investment Quick Answers
What is CUSIP N5436L119?
CUSIP N5436L119 identifies QUCY - MAINZ BIOMED N.V. - Ordinary Shares, nominal value of 0.01 per share in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Next ownership checks
Use the next link that matches the question you still need to answer about this security.
- Latest 13F filings when you want to inspect fresh institutional portfolio moves.
- Latest Schedule 13D/13G reports when you need large-owner changes outside the 13F cycle.
- All institutional ownership pages to compare this security with other holder-history pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP N5436L119:
Significant Owners of MAINZ BIOMED N.V. - Ordinary Shares, nominal value of 0.01 per share (QUCY) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 5% | -50% | $530,856 | +$134,575 | 435,128 | +34% | Armistice Capital, LLC | 31 Dec 2025 |
As of 31 Dec 2025, 18 institutional investors reported holding 1,131,702 shares of MAINZ BIOMED N.V. - Ordinary Shares, nominal value of 0.01 per share (QUCY). This represents 13% of the company’s total 8,720,000 outstanding shares.
Top 20 Institutional Shareholders
The largest institutional shareholders of MAINZ BIOMED N.V. - Ordinary Shares, nominal value of 0.01 per share (QUCY) together control 13% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 8.9% | 775,263 | +97% | 0.02% | $868,295 |
| Cerity Partners LLC | 1.9% | 163,253 | 0% | $182,843 | |
| UBS Group AG | 0.62% | 54,181 | +674% | 0% | $60,683 |
| Steward Partners Investment Advisory, LLC | 0.34% | 30,000 | +200% | 0% | $33,600 |
| Corient Private Wealth LLC | 0.23% | 20,000 | 0% | $22,400 | |
| JANE STREET GROUP, LLC | 0.21% | 18,437 | 0% | $20,650 | |
| Journey Advisory Group, LLC | 0.17% | 15,000 | 0% | 0% | $16,800 |
| TWO SIGMA SECURITIES, LLC | 0.15% | 13,208 | 0% | $14,793 | |
| Virtu Financial LLC | 0.15% | 12,814 | 0% | $14,000 | |
| CITADEL ADVISORS LLC | 0.14% | 12,643 | 0% | $14,160 | |
| CITIGROUP INC | 0.14% | 12,304 | +76800% | 0% | $13,780 |
| OSAIC HOLDINGS, INC. | 0.02% | 2,112 | 0% | 0% | $2,365 |
| Provenance Wealth Advisors, LLC | 0.01% | 1,171 | 0% | 0% | $1,312 |
| Newbridge Financial Services Group, Inc. | 0.01% | 500 | 0% | 0% | $560 |
| SBI Securities Co., Ltd. | 0% | 337 | 0% | 0% | $377 |
| HighMark Wealth Management LLC | 0% | 200 | 0% | $224 | |
| MORGAN STANLEY | 0% | 189 | +9350% | 0% | $212 |
| IFP Advisors, Inc | 0% | 90 | 0% | 0% | $101 |
| Dauntless Investment Group, LLC | 0% | 0 | -100% | $0 | |
| ROTHSCHILD INVESTMENT LLC | 0% | 0 | -100% | $0 |
Institutional Holders of MAINZ BIOMED N.V. - Ordinary Shares, nominal value of 0.01 per share (QUCY) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 1,261 | $598 | $0.48 | 2 | |
| 2025 Q4 | 1,131,702 | $1,267,155 | +$708,602 | $1.12 | 18 |
| 2025 Q3 | 481,831 | $717,864 | +$144,245 | $1.49 | 13 |
| 2025 Q2 | 385,627 | $543,733 | +$193,942 | $1.41 | 14 |
| 2025 Q1 | 234,899 | $754,173 | -$33,586 | $3.21 | 11 |
| 2024 Q4 | 245,330 | $1,059,640 | +$1,059,376 | $4.32 | 7 |